Logo image of CON

CONCENTRA GROUP HOLDINGS PAR (CON) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CON - US20603L1026 - Common Stock

21.99 USD
+0.08 (+0.37%)
Last: 1/21/2026, 8:05:52 PM
21.99 USD
0 (0%)
After Hours: 1/21/2026, 8:05:52 PM
Fundamental Rating

4

Overall CON gets a fundamental rating of 4 out of 10. We evaluated CON against 102 industry peers in the Health Care Providers & Services industry. CON has a medium profitability rating, but doesn't score so well on its financial health evaluation. CON has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year CON was profitable.
  • In the past year CON had a positive cash flow from operations.
CON Yearly Net Income VS EBIT VS OCF VS FCFCON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.33%, CON is in the better half of the industry, outperforming 78.43% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 39.35%, CON belongs to the top of the industry, outperforming 96.08% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 11.29%, CON belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CON is significantly above the industry average of 9.21%.
  • The last Return On Invested Capital (11.29%) for CON is well below the 3 year average (23.70%), which needs to be investigated, but indicates that CON had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.33%
ROE 39.35%
ROIC 11.29%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
CON Yearly ROA, ROE, ROICCON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60 80 100

1.3 Margins

  • The Profit Margin of CON (7.26%) is better than 88.24% of its industry peers.
  • CON's Profit Margin has declined in the last couple of years.
  • The Operating Margin of CON (15.61%) is better than 92.16% of its industry peers.
  • CON's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 28.36%, CON is in line with its industry, outperforming 56.86% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CON has declined.
Industry RankSector Rank
OM 15.61%
PM (TTM) 7.26%
GM 28.36%
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
CON Yearly Profit, Operating, Gross MarginsCON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15

3

2. Health

2.1 Basic Checks

  • CON has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • CON has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for CON is higher compared to a year ago.
CON Yearly Shares OutstandingCON Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
CON Yearly Total Debt VS Total AssetsCON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • CON has an Altman-Z score of 1.88. This is not the best score and indicates that CON is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CON's Altman-Z score of 1.88 is in line compared to the rest of the industry. CON outperforms 45.10% of its industry peers.
  • CON has a debt to FCF ratio of 9.18. This is a negative value and a sign of low solvency as CON would need 9.18 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 9.18, CON is in line with its industry, outperforming 47.06% of the companies in the same industry.
  • CON has a Debt/Equity ratio of 4.15. This is a high value indicating a heavy dependency on external financing.
  • CON has a worse Debt to Equity ratio (4.15) than 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.15
Debt/FCF 9.18
Altman-Z 1.88
ROIC/WACC1.28
WACC8.85%
CON Yearly LT Debt VS Equity VS FCFCON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B

2.3 Liquidity

  • A Current Ratio of 1.20 indicates that CON should not have too much problems paying its short term obligations.
  • The Current ratio of CON (1.20) is comparable to the rest of the industry.
  • CON has a Quick Ratio of 1.20. This is a normal value and indicates that CON is financially healthy and should not expect problems in meeting its short term obligations.
  • CON has a Quick ratio (1.20) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
CON Yearly Current Assets VS Current LiabilitesCON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

  • The earnings per share for CON have decreased strongly by -23.78% in the last year.
  • CON shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.99% yearly.
  • The Revenue for CON has decreased by -36.17% in the past year. This is quite bad
  • CON shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.14% yearly.
EPS 1Y (TTM)-23.78%
EPS 3Y-3.99%
EPS 5YN/A
EPS Q2Q%5.41%
Revenue 1Y (TTM)-36.17%
Revenue growth 3Y3.14%
Revenue growth 5YN/A
Sales Q2Q%16.98%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.11% on average over the next years. This is quite good.
  • CON is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.54% yearly.
EPS Next Y-6.11%
EPS Next 2Y3.62%
EPS Next 3Y6.6%
EPS Next 5Y8.11%
Revenue Next Year13.5%
Revenue Next 2Y10.47%
Revenue Next 3Y8.98%
Revenue Next 5Y8.54%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CON Yearly Revenue VS EstimatesCON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CON Yearly EPS VS EstimatesCON Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.59 indicates a rather expensive valuation of CON.
  • Based on the Price/Earnings ratio, CON is valued a bit cheaper than 79.41% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.32. CON is valued slightly cheaper when compared to this.
  • CON is valuated correctly with a Price/Forward Earnings ratio of 14.55.
  • Based on the Price/Forward Earnings ratio, CON is valued cheaper than 80.39% of the companies in the same industry.
  • CON is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.59
Fwd PE 14.55
CON Price Earnings VS Forward Price EarningsCON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CON's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CON is cheaper than 69.61% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CON indicates a somewhat cheap valuation: CON is cheaper than 75.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.05
EV/EBITDA 11
CON Per share dataCON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

  • The decent profitability rating of CON may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.62%
EPS Next 3Y6.6%

2

5. Dividend

5.1 Amount

  • CON has a Yearly Dividend Yield of 1.16%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.59, CON pays a better dividend. On top of this CON pays more dividend than 87.25% of the companies listed in the same industry.
  • CON's Dividend Yield is slightly below the S&P500 average, which is at 1.86.
Industry RankSector Rank
Dividend Yield 1.16%

5.2 History

  • CON does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
CON Yearly Dividends per shareCON Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • The earnings of CON are negative and hence is the payout ratio. CON will probably not be able to sustain this dividend level.
DP-991.33%
EPS Next 2Y3.62%
EPS Next 3Y6.6%
CON Yearly Income VS Free CF VS DividendCON Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 100M 200M 300M 400M 500M

CONCENTRA GROUP HOLDINGS PAR

NYSE:CON (1/21/2026, 8:05:52 PM)

After market: 21.99 0 (0%)

21.99

+0.08 (+0.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)03-02
Inst Owners90.19%
Inst Owner Change0.03%
Ins Owners8.07%
Ins Owner Change11.45%
Market Cap2.82B
Revenue(TTM)2.09B
Net Income(TTM)151.68M
Analysts81.82
Price Target28.56 (29.88%)
Short Float %3.28%
Short Ratio3.88
Dividend
Industry RankSector Rank
Dividend Yield 1.16%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-991.33%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.07%
Min EPS beat(2)-2.63%
Max EPS beat(2)2.78%
EPS beat(4)3
Avg EPS beat(4)0.49%
Min EPS beat(4)-2.63%
Max EPS beat(4)2.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.13%
Min Revenue beat(2)0.78%
Max Revenue beat(2)1.48%
Revenue beat(4)2
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)1.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.11%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-0.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 17.59
Fwd PE 14.55
P/S 1.35
P/FCF 16.05
P/OCF 11.08
P/B 7.31
P/tB N/A
EV/EBITDA 11
EPS(TTM)1.25
EY5.68%
EPS(NY)1.51
Fwd EY6.87%
FCF(TTM)1.37
FCFY6.23%
OCF(TTM)1.99
OCFY9.03%
SpS16.3
BVpS3.01
TBVpS-10.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.2
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 39.35%
ROCE 12.89%
ROIC 11.29%
ROICexc 11.52%
ROICexgc 38.19%
OM 15.61%
PM (TTM) 7.26%
GM 28.36%
FCFM 8.4%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
ROICexc(3y)24.7%
ROICexc(5y)N/A
ROICexgc(3y)89.31%
ROICexgc(5y)N/A
ROCE(3y)27.06%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 4.15
Debt/FCF 9.18
Debt/EBITDA 4.03
Cap/Depr 110.85%
Cap/Sales 3.77%
Interest Coverage 2.98
Cash Conversion 64.02%
Profit Quality 115.74%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 1.88
F-Score6
WACC8.85%
ROIC/WACC1.28
Cap/Depr(3y)84.37%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.64%
Cap/Sales(5y)N/A
Profit Quality(3y)135.77%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.78%
EPS 3Y-3.99%
EPS 5YN/A
EPS Q2Q%5.41%
EPS Next Y-6.11%
EPS Next 2Y3.62%
EPS Next 3Y6.6%
EPS Next 5Y8.11%
Revenue 1Y (TTM)-36.17%
Revenue growth 3Y3.14%
Revenue growth 5YN/A
Sales Q2Q%16.98%
Revenue Next Year13.5%
Revenue Next 2Y10.47%
Revenue Next 3Y8.98%
Revenue Next 5Y8.54%
EBIT growth 1Y-39%
EBIT growth 3Y-0.08%
EBIT growth 5YN/A
EBIT Next Year39.66%
EBIT Next 3Y17.73%
EBIT Next 5Y14.94%
FCF growth 1Y21.47%
FCF growth 3Y-3.19%
FCF growth 5YN/A
OCF growth 1Y17.23%
OCF growth 3Y-1.87%
OCF growth 5YN/A

CONCENTRA GROUP HOLDINGS PAR / CON FAQ

What is the fundamental rating for CON stock?

ChartMill assigns a fundamental rating of 4 / 10 to CON.


What is the valuation status of CONCENTRA GROUP HOLDINGS PAR (CON) stock?

ChartMill assigns a valuation rating of 5 / 10 to CONCENTRA GROUP HOLDINGS PAR (CON). This can be considered as Fairly Valued.


Can you provide the profitability details for CONCENTRA GROUP HOLDINGS PAR?

CONCENTRA GROUP HOLDINGS PAR (CON) has a profitability rating of 6 / 10.


How financially healthy is CONCENTRA GROUP HOLDINGS PAR?

The financial health rating of CONCENTRA GROUP HOLDINGS PAR (CON) is 3 / 10.


Can you provide the expected EPS growth for CON stock?

The Earnings per Share (EPS) of CONCENTRA GROUP HOLDINGS PAR (CON) is expected to decline by -6.11% in the next year.